Vitamin B5 also directly enhances the efficacy of anti-PD-L1 therapy in mice, while a higher pretreatment level of plasma pantothenic acid is associated with a better response to anti-PD-L1 therapy in patients with MM [173]. The gene discussed is CD274; the disease is Miyoshi myopathy.